Astrazeneca’s boss has warned Europe is falling behind as it steps up investment in the United States.

Pascal Soriot said innovation in pharmaceuticals ‘has mostly been funded by the US’ as he doubled down on plans to grow the business in America – which already accounts for 40 per cent of revenues.